Market revenue in 2024 | USD 882.5 million |
Market revenue in 2030 | USD 1,641.6 million |
Growth rate | 10.9% (CAGR from 2025 to 2030) |
Largest segment | Psoriasis |
Fastest growing segment | Psoriasis |
Historical data | 2018 - 2023 |
Base year | 2024 |
Forecast period | 2025 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Acne, Psoriasis, Rosacea, Alopecia |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to dermatological drugs market will help companies and investors design strategic landscapes.
Psoriasis was the largest segment with a revenue share of 39.95% in 2024. Horizon Databook has segmented the UK dermatological drugs market based on acne, psoriasis, rosacea, alopecia covering the revenue growth of each sub-segment from 2018 to 2030.
The dermatological drugs market in the UK is experiencing steady growth, driven by the rising prevalence of skin conditions such as acne, eczema, psoriasis, and other chronic dermatological disorders. The increasing awareness of skin health, alongside advancements in treatment options, particularly biologics, is contributing significantly to market expansion.
The country’s well-established healthcare system and government support for healthcare access also play a pivotal role in sustaining the growth of the market. Key factors contributing to this growth include the aging population and the rising number of people with chronic dermatological conditions. As the UK population ages, there is a greater demand for treatments addressing age-related skin disorders, including psoriasis and eczema.
The availability of innovative treatments, such as biologics and targeted therapies, has further bolstered market development. The ongoing evolution of the UK healthcare system, which ensures access to specialized dermatological care, continues to support the increasing demand for dermatology drugs.
Horizon Databook provides a detailed overview of country-level data and insights on the UK dermatological drugs market , including forecasts for subscribers. This country databook contains high-level insights into UK dermatological drugs market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
No related regions found.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account